VAERS reports by lot

GSK Varicella/Shingles lot C7244: VAERS reports

20 VAERS reports list lot C7244 as a GSK Varicella/Shingles vaccine, received between 2020-05-21 and 2022-07-13. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
5%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2336%
Musculoskeletal1117%
Dermatological (non-injection-site)711%
General / Systemic (non-local)711%
Allergic / Anaphylactic69%
Gastrointestinal46%
Neurological35%
Cardiac / Cardiovascular23%
Autoimmune / Immune-mediated12%

Where reports came from

U.S. state of the reporter, where given (top 10).

Florida4
Pennsylvania4
Ohio3
South Carolina2
Virginia2
Indiana1
Illinois1
Colorado1
Missouri1
Hawaii1

Reports by month received

2020-051
2020-062
2020-071
2020-087
2020-102
2020-113
2021-011
2021-051
2021-111
2022-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.